Belarus is one of the potential beneficiaries of the EU-funded EU4Monitoring Drugs (EU4MD) project, which has been developed by the EMCDDA as part of its ongoing commitment to strengthening cooperation and sharing expertise with countries in the European Neighbourhood Policy (ENP) area.